Not all FAANGs are the same – some have more teeth than others
Just over a week after Facebook lost a fifth of its value in a day, Apple became the first trillion…
6 years ago
Latest
DeepMatter boosted by new deals
AIM-listed digital chemistry outfit DeepMatter saw its shares climb by 9.29% to 3.82p after the firm announced three new deals.
6 years ago
Hikma Pharmaceuticals rises on strong revenues and profits
Shares in Hikma Pharmaceuticals climbed by 8.38% to 1,785p (as of 12:30 BST) after group revenues rose by 11% during…
6 years ago
Balfour Beatty profit soars on weaker revenues
FTSE 250 infrastructure firm Balfour Beatty has reported pre-tax profits of £50 million for the first half, a 150% improvement…
6 years ago
FinTech will change markets – from fundraising to settlement and regulation
This article focuses on how FinTech is changing capital markets and asks whether FinTech firms will be disruptors or collaborators.
6 years ago
Napa Therapeutics formed to target age-linked illnesses
The Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence announced that they have formed Napa Therapeutics to develop…
6 years ago
Antofagasta raises revenues but profits weaken
FTSE 100 miner Antofagasta increased revenues by 3.6% to $2,120.7 million as higher realised prices outweighed lower volumes in copper…
6 years ago
Esure recommends Bain buyout
Digital insurance outfit Esure has agreed an all cash recommended offer with a subsidiary of funds managed by Bain Capital.
6 years ago
The fund that has outperformed in 14 of the last 15 years
Neil Hermon’s excellent long-term track record in charge of the Henderson Smaller Companies investment trust has transformed the fund into…
6 years ago
Fusion Antibodies warns on revenues and profits
AIM-listed Fusion Antibodies has warned that trading this year has been slower than expected, as competition has led to lower prices…
6 years ago